Literature DB >> 23596205

Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.

Adam A Margolin1, Erhan Bilal, Erich Huang, Thea C Norman, Lars Ottestad, Brigham H Mecham, Ben Sauerwine, Michael R Kellen, Lara M Mangravite, Matthew D Furia, Hans Kristian Moen Vollan, Oscar M Rueda, Justin Guinney, Nicole A Deflaux, Bruce Hoff, Xavier Schildwachter, Hege G Russnes, Daehoon Park, Veronica O Vang, Tyler Pirtle, Lamia Youseff, Craig Citro, Christina Curtis, Vessela N Kristensen, Joseph Hellerstein, Stephen H Friend, Gustavo Stolovitzky, Samuel Aparicio, Carlos Caldas, Anne-Lise Børresen-Dale.   

Abstract

Although molecular prognostics in breast cancer are among the most successful examples of translating genomic analysis to clinical applications, optimal approaches to breast cancer clinical risk prediction remain controversial. The Sage Bionetworks-DREAM Breast Cancer Prognosis Challenge (BCC) is a crowdsourced research study for breast cancer prognostic modeling using genome-scale data. The BCC provided a community of data analysts with a common platform for data access and blinded evaluation of model accuracy in predicting breast cancer survival on the basis of gene expression data, copy number data, and clinical covariates. This approach offered the opportunity to assess whether a crowdsourced community Challenge would generate models of breast cancer prognosis commensurate with or exceeding current best-in-class approaches. The BCC comprised multiple rounds of blinded evaluations on held-out portions of data on 1981 patients, resulting in more than 1400 models submitted as open source code. Participants then retrained their models on the full data set of 1981 samples and submitted up to five models for validation in a newly generated data set of 184 breast cancer patients. Analysis of the BCC results suggests that the best-performing modeling strategy outperformed previously reported methods in blinded evaluations; model performance was consistent across several independent evaluations; and aggregating community-developed models achieved performance on par with the best-performing individual models.

Entities:  

Mesh:

Year:  2013        PMID: 23596205      PMCID: PMC3897241          DOI: 10.1126/scitranslmed.3006112

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  33 in total

1.  Revealing strengths and weaknesses of methods for gene network inference.

Authors:  Daniel Marbach; Robert J Prill; Thomas Schaffter; Claudio Mattiussi; Dario Floreano; Gustavo Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

2.  A large-scale experiment to assess protein structure prediction methods.

Authors:  J Moult; J T Pedersen; R Judson; K Fidelis
Journal:  Proteins       Date:  1995-11

3.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Supervised normalization of microarrays.

Authors:  Brigham H Mecham; Peter S Nelson; John D Storey
Journal:  Bioinformatics       Date:  2010-03-31       Impact factor: 6.937

6.  Towards a rigorous assessment of systems biology models: the DREAM3 challenges.

Authors:  Robert J Prill; Daniel Marbach; Julio Saez-Rodriguez; Peter K Sorger; Leonidas G Alexopoulos; Xiaowei Xue; Neil D Clarke; Gregoire Altan-Bonnet; Gustavo Stolovitzky
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

7.  Predicting protein structures with a multiplayer online game.

Authors:  Seth Cooper; Firas Khatib; Adrien Treuille; Janos Barbero; Jeehyung Lee; Michael Beenen; Andrew Leaver-Fay; David Baker; Zoran Popović; Foldit Players
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

8.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

9.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

10.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

View more
  60 in total

1.  Crowdsourced contest identifies best-in-class breast cancer prognostic.

Authors:  Michael Eisenstein
Journal:  Nat Biotechnol       Date:  2013-07       Impact factor: 54.908

2.  Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data.

Authors:  In Sock Jang; Elias Chaibub Neto; Juistin Guinney; Stephen H Friend; Adam A Margolin
Journal:  Pac Symp Biocomput       Date:  2014

Review 3.  Principles and methods of integrative genomic analyses in cancer.

Authors:  Vessela N Kristensen; Ole Christian Lingjærde; Hege G Russnes; Hans Kristian M Vollan; Arnoldo Frigessi; Anne-Lise Børresen-Dale
Journal:  Nat Rev Cancer       Date:  2014-05       Impact factor: 60.716

4.  DREAMing of benchmarks.

Authors:  Irene Jarchum; Susan Jones
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

5.  Regulatory network inferred using expression data of small sample size: application and validation in erythroid system.

Authors:  Fan Zhu; Lihong Shi; James Douglas Engel; Yuanfang Guan
Journal:  Bioinformatics       Date:  2015-04-02       Impact factor: 6.937

Review 6.  Crowdsourcing in biomedicine: challenges and opportunities.

Authors:  Ritu Khare; Benjamin M Good; Robert Leaman; Andrew I Su; Zhiyong Lu
Journal:  Brief Bioinform       Date:  2015-04-17       Impact factor: 11.622

7.  Ranking and combining multiple predictors without labeled data.

Authors:  Fabio Parisi; Francesco Strino; Boaz Nadler; Yuval Kluger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 8.  Crowdsourcing biomedical research: leveraging communities as innovation engines.

Authors:  Julio Saez-Rodriguez; James C Costello; Stephen H Friend; Michael R Kellen; Lara Mangravite; Pablo Meyer; Thea Norman; Gustavo Stolovitzky
Journal:  Nat Rev Genet       Date:  2016-07-15       Impact factor: 53.242

9.  Similarity network fusion for aggregating data types on a genomic scale.

Authors:  Bo Wang; Aziz M Mezlini; Feyyaz Demir; Marc Fiume; Zhuowen Tu; Michael Brudno; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  Nat Methods       Date:  2014-01-26       Impact factor: 28.547

Review 10.  Machine Learning in Medicine.

Authors:  Rahul C Deo
Journal:  Circulation       Date:  2015-11-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.